Evidence map›Paper›PMID 28108183›Full record

ArticleJournal of virological methods2017

Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.

Zhu-Nan Li, Kimberly M Weber, Rebecca A Limmer, Bobbi J Horne, James Stevens, Joy Schwerzmann, Jens Wrammert, Megan McCausland, Andrew J Phipps, Kathy Hancock and 4 more

Open access · greenAbstract readComparative StudyEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virological methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Zhu-Nan LiInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA. Electronic address: hix7@cdc.gov.
Kimberly M WeberBattelle Memorial Institute, Columbus, OH 43201, USA.
Rebecca A LimmerBattelle Memorial Institute, Columbus, OH 43201, USA.
Bobbi J HorneBattelle Memorial Institute, Columbus, OH 43201, USA.
James StevensInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA.
Joy SchwerzmannBattelle Memorial Institute, Columbus, OH 43201, USA.
Jens WrammertEmory Vaccine Center, Emory University, Atlanta, GA 30322, USA.
Megan McCauslandEmory Vaccine Center, Emory University, Atlanta, GA 30322, USA.
Andrew J PhippsBattelle Memorial Institute, Columbus, OH 43201, USA.
Kathy HancockInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA.
Daniel B JerniganInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA.
Min LevineInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA.
Jacqueline M KatzInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA. Electronic address: jmk9@cdc.gov.
Joseph D MillerInfluenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027 USA.
Battelle · USCenters for Disease Control and Prevention · USNational Center for Immunization and Respiratory Diseases · USEmory University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Influenza hemagglutination inhibition (HI) and virus microneutralization assays (MN) are widely used for seroprevalence studies. However, these assays have limited field portability and are difficult to fully automate for high throughput laboratory testing. To address these issues, three multiplex influenza subtype-specific antibody detection assays were developed using recombinant hemagglutinin antigens in combination with Chembio, Luminex

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ViralChildChild, PreschoolHemagglutinin Glycoproteins, Influenza VirusHigh-Throughput Screening AssaysHumansInfluenza, HumanMiddle AgedSensitivity and SpecificitySerologic TestsYoung AdultAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusAntibodyAntibody biosensor assayChembioHemagglutininInfluenzaLuminex(®)

Identifiers

PMID28108183
PMCPMC8958803
OpenAlexW2572022229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.